Anna Maria Geretti, MD, PhD - Understanding an Individual’s Readiness for Long-Acting Injectable Therapy

Visit https://www.peervoice.com/ZCC860 to view the entire programme with slides. After completing “Anna Maria Geretti, MD, PhD - Understanding an Individual’s Readiness for Long-Acting Injectable Therapy”, participants will be able to: Describe the eligibility criteria and patient factors that impact whether long-acting injectable antiretroviral therapy (LAI-ART) is a treatment option for an individual with HIV; Explain key information that individuals with HIV need to know about the potential benefits and limitations of LAI-ART in order for them to be able to make informed decisions on their LAI-ART readiness; and Use clinical factors and patient characteristics to evaluate an individual’s eligibility and readiness for LAI-ART.